A Corvus director bought 1.285M shares, while ALJ Regional Holdings' chairman sold 276K shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from February 15 through February 19 include:
- Beneficial owner of Molecular Templates (MTEM) Biotech Target purchased 1,185,770 shares of stock at $12.65 per share for a total transaction amount of $14,999,991
- Director of Corvus Pharmaceuticals (CRVS) Peter Thompson purchased 1,285,714 shares of stock at $3.50 per share for a total transaction amount of $4,499,999
- Beneficial owner of Applied Therapeutics (APLT) Alexandria Real Estate Equities purchased 43,478 shares of stock at $23.00 per share for a total transaction amount of $999,994
- Director of SLM Corp (SLM) Mary Carter Franke purchased 7,000 shares of stock at $15.03 per share for a total transaction amount of $105,193
NOTABLE INSIDER SALES: Significant insider sales in the prior week from February 15 through February 19 include:
- Chairman of Arrow Electronics (ARW) Michael Long sold 97,249 shares of stock at $103.34 per share for a total transaction amount of $10,049,712
- Chairman of Altair Engineering (ALTR) James Scapa sold 3,755 shares of stock at $61.11 per share for a total transaction amount of $229,483
- Director of Abeona Therapeutics (ABEO) Todd Wider sold 321,345 shares of stock at $2.34 per share for a total transaction amount of $753,072
- Chairman of ALJ Regional Holdings (ALJJ) sold 276,237 shares of stock at $1.80 Todd Wider sold 321,345 shares of stock at $2.34 $498,470
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Corvus Pharmaceuticals is up 23% after director Peter Thompson purchased $5M in company shares, while ALJ Regional Holdings is down 14% after chairman Jess Ravich sold $498K in shares.
Symbols:
MTEM CRVS APLT SLM ARW ALTR ABEO ALJJ Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC